top of page
DAN CHICHESTER
Writing | Creative Direction | Digital Strategy
PD-L1/Pitch
Building awareness and anticipation around the science and potential of Tecentriq's anti-PD-L1 cancer immunotherapy.
bottom of page
Building awareness and anticipation around the science and potential of Tecentriq's anti-PD-L1 cancer immunotherapy.